P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 501–600 of 1,000
A Selective Reduction of Osteosarcoma by Mitochondrial Apoptosis Using Hydroxyapatite Nanoparticles
Wu, H., Liu, S., Chen, S., Hua, Y., Li, X., Zeng, Q., Zhou, Y., Yang, X., Zhu, X., Tu, C., et al. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s375950 · Cited by 23
Zhang, H., Zhang, W., Hu, B., Qin, X., Yi, T., Ye, Y., Huang, X., Song, Y., Yang, Z., Qian, J., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01867-6 · Cited by 24
“Background The p53 protein that encodes by TP53 gene, is one of the most important tumor suppressors which regulates the transcription of a large number of downstream target genes that serves to cell proliferation, apoptosis, and metabolism [1, 2].”
BackgroundLi, R., Wu, Y., Li, Y., Wen, S., Wang, A., Zhu, Y., Hu, X., Xia, Y., Ouyang, L., & Wang, G. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.116040 · Cited by 28
Sirtuins in intervertebral disc degeneration: current understanding
Shen, J., Lan, Y., Ji, Z., & Liu, H. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00811-0 · Cited by 27
Recognition by natural killer cells of N6‐isopentenyladenosine‐treated human glioma cell lines
Ciaglia, E., Laezza, C., Abate, M., Pisanti, S., Ranieri, R., D’Alessandro, A., Picardi, P., Gazzerro, P., & Bifulco, M. (2017) · International Journal of Cancer · doi:10.1002/ijc.31036 · Cited by 23
Duan, L., Perez, R. E., Chen, L., Blatter, L. A., & Maki, C. G. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx051 · Cited by 24
The SUMO‐specific protease SENP1 deSUMOylates p53 and regulates its activity
Chauhan, K. M., Chen, Y., Chen, Y., Liu, A. T., Sun, X., & Dai, M. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29838 · Cited by 24
Mesenchymal stem cells ameliorate cisplatin-induced acute kidney injury via let-7b-5p
Wang, S., Xu, Y., Hong, Q., Chen, X., & Cai, G. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03729-3 · Cited by 23
Polachini, G. M., de Castro, T. B., Smarra, L. F. S., Henrique, T., de Paula, C. H. D., Severino, P., López, R. V. M., Carvalho, A. L., Zeri, A. C. D. M., Silva, I. D. C. G., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-34808-2 · Cited by 24
Oikawa, T., Otsuka, Y., Onodera, Y., Horikawa, M., Handa, H., Hashimoto, S., Suzuki, Y., & Sabe, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-20043-7 · Cited by 24
Rizzo, M., Beffy, P., Carratore, R. D., Falleni, A., Pretini, V., D’Aurizio, R., Botta, A., Evangelista, M., Stoccoro, A., Coppedè, F., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1080-1 · Cited by 24
Transcriptional versus metabolic control of cell fitness during cell competition
Lawlor, K., Pérez-Montero, S., Lima, A., & Rodríguez, T. A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.010 · Cited by 23
Zong, Y., Li, Q., Zhang, F., Xian, X., Wang, S., Xia, J., Li, J., Tuo, Z., Xiao, G., Liu, L., et al. (2019) · Theranostics · doi:10.7150/thno.34443 · Cited by 24
Baudier, J., & Gentil, B. J. (2020) · Biomolecules · doi:10.3390/biom10060843 · Cited by 22
“The protein p53 is a short-lived transcriptional regulator that, in response to various forms of cellular stress, is translocated to the nucleus in order to control the expression of a variety of genes involved in metabolism, cell cycle arrest, and cell death [42–44].”
BackgroundTIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway
Ghoshal-Gupta, S., Kutiyanawalla, A., Lee, B. R., Ojha, J., Nurani, A., Mondal, A. K., Kolhe, R. B., Rojiani, A. M., & Rojiani, M. V. (2018) · Oncotarget · doi:10.18632/oncotarget.23832 · Cited by 21
“The classical documented function of p53 is as a transcription factor that controls the expression of a large cohort of genes under stress conditions [41].”
BackgroundChen, C., Wang, T., Yang, M., Song, J. T., Huang, M., Bai, Y., & Su, H. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609879 · Cited by 21
Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway
Long, L., Zhang, X., Wen, Y., Li, J., Wei, L., Cheng, Y., Liu, H., Chu, J., Fang, Y., Xie, Q., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770863 · Cited by 22
“As one of the key regulators of apoptosis, p53 can be activated and stabilized through post-translational modification pathways, including ubiquitination, phosphorylation, and acetylation (Kruiswijk et al., 2015).”
BackgroundNoncoding RNAs in the Glycolysis of Ovarian Cancer
Zhang, C., & Liu, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.855488 · Cited by 26
“…TP53mediated glycolysis and apoptosis-inducing factor expression (Strycharz et al., 2017; Itahana and Itahana 2018; Smiles and Camera 2018), regulating mitochondrial respiratory function, pentose phosphate pathway, and glycolysis-related enzymes (Kruiswijk et al., 2015; Werner et al., 2016).”
BackgroundGe, Y., Zhao, R., Li, B., Xiao, B., Zhou, L., & Zuo, S. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113377 · Cited by 24
PML nuclear bodies, membrane-less domains acting as ROS sensors?
Niwa‐Kawakita, M., Wu, H.-C., de Thé, H., & Lallemand-Breitenbach, V. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.11.007 · Cited by 21
Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice
Fraszczak, J., Vadnais, C., Rashkovan, M., Ross, J., Beauchemin, H., Chen, R., Grapton, D., Khandanpour, C., & Möröy, T. (2018) · Leukemia · doi:10.1038/s41375-018-0166-1 · Cited by 26
“In the absence of Gfi1, p53 is, therefore, highly methylated at this residue and active [15] and accelerates programmed cell death in hematopoietic cells upon a stress signal [15, 62].”
BackgroundLøvmo, S. D., Whatmore, P., Sundh, H., Sigholt, T., Madaro, A., Bardal, T., & Olsen, R. E. (2021) · Aquaculture · doi:10.1016/j.aquaculture.2021.736653 · Cited by 23
Kwon, H. W., Lee, J. H., Pahk, K., Park, K. H., & Kim, S. (2021) · Cancer Imaging · doi:10.1186/s40644-021-00424-4 · Cited by 26
Pham, K., Hanaford, A. R., Poore, B., Maxwell, M. J., Sweeney, H., Parthasarathy, A., Alt, J., Rais, R., Slusher, B. S., Eberhart, C. G., et al. (2022) · Cancers · doi:10.3390/cancers14051311 · Cited by 22
Mirkovic, M., Guilgur, L., Tavares, A., Passagem-Santos, D., & Oliveira, R. A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000016 · Cited by 21
“They can lead to different aneuploidy-associated responses that include oxidative, metabolic, replication, and proteotoxic stress, which likely contribute to p53 activation and, in most cases, cell senescence and/or cell death [43].”
The Role of S-Glutathionylation in Health and Disease: A Bird’s Eye View
Federici, L., Masulli, M., Laurenzi, V. D., & Allocati, N. (2024) · Nutrients · doi:10.3390/nu16162753 · Cited by 21
“A p53 response can be activated by several types of stress, including DNA damage, oxygen deprivation, and variations in nutrient levels, supporting cell survival and defense from tumorigenesis [68].”
BackgroundLACE1 interacts with p53 and mediates its mitochondrial translocation and apoptosis
Cesnekova, J., Křížová, J., Hansíková, H., Houštěk, J., Zeman, J., & Stibůrek, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9959 · Cited by 20
“Tumor suppressor p53 represents a central molecule of a complex cellular stress signaling pathway [1, 2].”
BackgroundShaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures
Karakostis, K., & Fåhræus, R. (2019) · BMC Cancer · doi:10.1186/s12885-019-6118-y · Cited by 21
Jin, Q., Zuo, W., Lin, Q., Wu, T., Liu, C., Liu, N., Liu, J., & Zhu, X. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.07.003 · Cited by 8
The SUMOylation and ubiquitination crosstalk in cancer
Li, K., Xia, Y., He, J., Wang, J., Li, J., Ye, M., & Jin, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05310-z · Cited by 25
“P53 is a transcription factor that acts as a tumor suppressor by regulating various biological behaviors such as cell cycle arrest, apoptosis, senescence, DNA repair and cell metabolism (Kruiswijk et al. 2015; Devine and Dai 2013).”
BackgroundCheng, Y., Wang, X., Huang, S., Zhang, L., Lan, B., Li, X., Chen, X., Liu, Z., Su, Y., Xi, L., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102063 · Cited by 20
“33,34 In our study, we discovered a novel mechanism p53 explores to regulate ferroptosis.”
BackgroundMolecular mechanisms involved in gliomagenesis
Kondo, T. (2017) · Brain Tumor Pathology · doi:10.1007/s10014-017-0278-8 · Cited by 22
“p53 was originally found as an essential tumor suppressor preventing cell cycle progression and inducing apoptosis [51].”
P53 at the start of the 21st century: lessons from elephants
Haupt, S., & Haupt, Y. (2017) · F1000Research · doi:10.12688/f1000research.12682.1 · Cited by 22
“In response to a range of cellular stresses, p53 transactivates multiple target genes to regulate a range of outcomes, including cell growth arrest, apoptosis, DNA damage repair, oncogene activation, telomere shortening and metabolic disturbance (reviewed in 29).”
BackgroundDelay in development and behavioural abnormalities in the absence of p53 in zebrafish
Elabd, S., Jabeen, N. A., Gerber, V., Peravali, R., Bourdon, J., Kancherla, S., Vallone, D., & Blattner, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220069 · Cited by 22
Functional interplay between p53 and Δ133p53 in adaptive stress response
Gong, L., Pan, X., Abali, G. K., Little, J. B., & Yuan, Z.-M. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0445-z · Cited by 20
Interplay between HMGA and TP53 in cell cycle control along tumor progression
Costa, N. M. D., Palumbo, A., Martino, M. D., Fusco, A., Pinto, L. F. R., & Nasciutti, L. E. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03634-4 · Cited by 21
“Therefore, p53 is stabilized and its levels are increased in cells, enabling the transactivation of its target genes and execution of its crucial cellular functions [56, 62, 63].”
BackgroundDEPTOR is a direct p53 target that suppresses cell growth and chemosensitivity
Cui, D., Dai, X.-Q., Gong, L., Chen, X., Wang, L., Xiong, X., & Zhao, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03185-3 · Cited by 22
Sestrins are Gatekeepers in the Way from Stress to Aging and Disease
Dalina, A. A., Kovaleva, I. E., & Budanov, A. V. (2018) · Molecular Biology · doi:10.1134/s0026893318060043 · Cited by 20
A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation
Kazantseva, M., Mehta, S. Y., Eiholzer, R. A., Hung, N. A., Wiles, A. K., Slatter, T. L., & Braithwaite, A. W. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9758-3 · Cited by 23
Ahmed, M. A. H., O'Callaghan, C., Chang, E. D., Jiang, H., & Vassilopoulos, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01462 · Cited by 20
Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis—A connection to licensing nodes
Schneeweis, C., Wirth, M., Saur, D., Reichert, M., & Schneider, G. (2016) · Small GTPases · doi:10.1080/21541248.2016.1262935 · Cited by 21
“wild type p53 to impair glycolysis and to promote mitochondrial respiration.(35) In PDAC cells, glucose fluxes to”
BackgroundLive imaging of late-stage preimplantation human embryos reveals de novo mitotic errors
Abdelbaki, A., McCarthy, A., Karsa, A., Mureşan, L., Elder, K. T., Papathanasiou, A., Snell, P., Christie, L., Wilding, M., Steventon, B., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02851-1 · Cited by 22
“This suggests that early embryonic cells possess distinct mechanisms for tolerating mitotic errors during preimplantation development, in contrast to somatic cells, where such errors typically trigger cell death 45–47 .”
Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension
Ma, W., Qiu, Z., Bai, Z., Dai, Y., Li, C., Chen, X., Song, X., Shi, D., Zhou, Y., Pan, Y., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.09.007 · Cited by 19
“The function of P53 as a major regulatory protein has been attributed to its involvement in cell proliferation, DNA repair, and cell cycle control.(25) In particular, P53 functions as both a sensitizer(26) and an activator(27) of apoptosis,(26) as well as in PAH.”
BackgroundThe Potential of Omics in Biological Dosimetry
Hladik, D., Bucher, M., Endesfelder, D., & Oestreicher, U. (2022) · Radiation · doi:10.3390/radiation2010006 · Cited by 21
Lv, W., Liao, J., Li, C., Liu, D., Luo, X., Diao, R., Wang, Y., & Jin, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1443108 · Cited by 21
Saeed, T., Ahmad, J., Kanwal, S., Holowatyj, A. N., Sheikh, I. A., Paracha, R. Z., Shafi, A., Siddiqa, A., Bibi, Z., Khan, M., et al. (2016) · PeerJ · doi:10.7717/peerj.2348 · Cited by 20
Fang, X., Lu, G., Ha, K., Lin, H., Ye, D., Zuo, Q., Fu, Y., Zou, C., & Zhang, P. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.028 · Cited by 23
Alaee, M., Nool, K., & Pasdar, M. (2018) · Cancer Science · doi:10.1111/cas.13612 · Cited by 19
“p53 is a sequence-specific transcription factor with tumor and metastasis suppressor activities.(1,2) It plays pivotal roles in the regulation of the cell cycle, DNA repair, senescence, apoptosis, and meta-”
BackgroundWalerych, D., Pruszko, M., Zyla, L., Wężyk, M., Gawęda-Walerych, K., & Żylicz, M. (2018) · Oncotarget · doi:10.18632/oncotarget.25944 · Cited by 21
“…p53 tumor-suppressive transactivation, which leads to severe physiologic consequences in cells - apoptosis, cell cycle arrest and metabolic reprogramming [44] and thus possibly influences the p53-CFP/YFP turnover, localization or folding - is decisive for the more efficient wt p53 oligomerization.”
ZNF185 is a p53 target gene following DNA damage
Smirnov, A., Cappello, A., Lena, A. M., Anemona, L., Mauriello, A., Daniele, N. D., Annicchiarico‐Petruzzelli, M., Melino, G., & Candi, E. (2018) · Aging · doi:10.18632/aging.101639 · Cited by 25
Austin, E., Huang, A., Wang, J. Y., Cohen, M., Heilman, E. R., Maverakis, E., Michl, J., & Jagdeo, J. R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.928484 · Cited by 20
HUR protectsNONOfrom degradation by mir320, which is induced by p53 upon UV irradiation
Alfano, L., Costa, C., Caporaso, A., Antonini, D., Giordano, A., & Pentimalli, F. (2016) · Oncotarget · doi:10.18632/oncotarget.13002 · Cited by 19
“As mir320a has been shown to reduce glycolysis by direct targeting key enzymes of this process [34], we can speculate that the p53-induced mir320a upregulation upon irradiation might underlie the complex p53 response, which includes the regulation of metabolic pathways — such as glycolysis restriction and oxidative ph…”
BackgroundCho, H., Zhao, X.-X., Lee, S., Woo, J. S., Song, M., Cheng, X. W., Lee, K. H., & Kim, W. (2021) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-021-00487-5 · Cited by 20
Agamia, N., Mulla, K. F. E., Alsayed, N. M., Ghazala, R. A., Abdelmaksoud, R., Abdelmeniem, I. M., Talaat, I. M., Zaki, I. I., Sabah, R. M., & Melnik, B. C. (2022) · Archives of Dermatological Research · doi:10.1007/s00403-022-02508-y · Cited by 26
Review of ferroptosis in colorectal cancer: Friends or foes?
Wu, Z., Fang, Z.-X., Hou, Y.-Y., Wu, B., Deng, Y., Wu, H.-T., & Liu, J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i3.469 · Cited by 22
Ferroptosis: An Emerging Target for Bladder Cancer Therapy
Shan, Z., Tang, W., Shi, Z., & Shan, T. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100517 · Cited by 18
“…in the regulation of carcinogenesis by modulating ferroptosis in cancer cells [45,46]. p53 may have pro-or anti-ferroptosis effects on oxidative stress. p53 might act as a rheostat, preventing ferroptosis under basal or low ROS stress and promoting ferroptosis under high oxidative stress [47,48].”
BackgroundCharacterization, expression and silencing by RNAi of p53 from Penaeus monodon
Dai, W., Qiu, L., Zhao, C., Fu, M., Ma, Z., Zhou, F., & Yang, Q. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-3988-9 · Cited by 20
Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells
Grespi, F., Landré, V., Molchadsky, A., Daniele, N. D., Marsella, L., Melino, G., & Rotter, V. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.419 · Cited by 18
Small Molecules Targeting Mutant P53: A Promising Approach for Cancer Treatment
Lopes, E. A., Gomes, S., Saraiva, L., & Santos, M. M. M. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867325666181116124308 · Cited by 14
Zamorano‐León, J. J., Ballesteros, S., Heras, N. D. L., Álvarez-Sala, L., de la Serna-Soto, M., Zekri-Nechar, K., Freixer, G., Rico, B. C., Yang, Z., García‐García, J. M., et al. (2019) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2019.24.2.187 · Cited by 19
“Translocation of the tumor suppression protein p53 to the nucleus is thought to be pivotal for stimulating both cellular apoptosis and senescence (Kruiswijk et al., 2015).”
BackgroundBiomimetic Synthesis of Rhytidenone A and Mode of Action of Cytotoxic Rhytidenone F
Yue, Z., Lam, H. C., Chen, K., Siridechakorn, I., Liu, Y., Pudhom, K., & Lei, X. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201914257 · Cited by 18
A molecular dynamics and docking study to screen anti-cancer compounds targeting mutated p53
Shah, H. D., Saranath, D., & Murthy, V. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1839559 · Cited by 20
“…is a key regulator of several biological functions in cells including proliferation, apoptosis, metabolism, DNA repair, autophagy, differentiation, stem cell reprogramming, motility, and senescence, often deregulated in the process of carcinogenesis (Kruiswijk et al., 2015; Zilfou & Lowe, 2009).”
BackgroundHyder, U., McCann, J. L., Wang, J., Fung, V., Bayo, J., & D’Orso, I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2004470117 · Cited by 22
Levandowski, C. B., Jones, T., Gruca, M. A., Ramamoorthy, S., Dowell, R. D., & Taatjes, D. J. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3001364 · Cited by 19
“As a tumor suppressor, p53 significantly impacts cell metabolism [5].”
Loss of tumor protein 53 protects against alcohol‐induced facial malformations in mice and zebrafish
Fish, E. W., Tucker, S. K., Peterson, R. L., Eberhart, J. K., & Parnell, S. E. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14688 · Cited by 19
Barili, V., Vecchi, A. L., Rossi, M., Montali, I., Tiezzi, C., Penna, A., Laccabue, D., Missale, G., Fisicaro, P., & Boni, C. (2021) · Cells · doi:10.3390/cells10102563 · Cited by 22
Metabolic and DNA checkpoints for the enhancement of Al tolerance
Siqueira, J. A., Silva, M. F., Wakin, T., Nunes‐Nesi, A., & Araújo, W. L. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128366 · Cited by 18
Gong, L., Pan, X., Lim, C.-B., de Polo, A., Little, J. B., & Yuan, Z.-M. (2018) · Oncogene · doi:10.1038/s41388-017-0117-8 · Cited by 18
“The tumor-suppressor p53 is most known for its antiproliferative and pro-apoptotic functions but more recently in cell metabolism [1].”
BackgroundProtein Kinase-Mediated Decision Between the Life and Death
Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_1 · Cited by 25
Non-Coding RNAs in Gastric Cancer: From Malignant Hallmarks to Clinical Applications
Chen, D., Ping, S., Xu, Y., Wang, M., Jiang, X., Xiong, L., Zhang, L., Yu, H., & Xiong, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732036 · Cited by 20
Xie, Y., Chen, H., Tian, M., Wang, Z., Wang, L., Zhang, J., Wang, X., & Lian, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460547 · Cited by 22
Effects of uric acid on oxidative stress in vascular smooth muscle cells
Doğru, S., Yaşar, E., & Yeşilkaya, A. (2024) · Biomedical Reports · doi:10.3892/br.2024.1859 · Cited by 19
“However, when cells are exposed to excessive and/or prolonged ROS levels, which can cause uncontrollable damage, p53 activity is inhibited by ROS, leading to cell death pathways to protect adjacent undamaged cells (83,84).”
BackgroundMDM2 oligomers: antagonizers of the guardian of the genome
Leslie, P. L., & Zhang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.88 · Cited by 19
Targeting Oxidative Stress: A Novel Approach in Mitigating Cancer
Sil, P. C. (2015) · Biochemistry & Analytical Biochemistry · doi:10.4172/2161-1009.1000236 · Cited by 17
“As mentioned earlier the tumour suppressor genes get suppressed during the development of cancer, but the suppression of several tumour suppressor genes results in upregulation or downregulation of various antioxidant genes [15].”
BackgroundMachida, K. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7241 · Cited by 18
“Loss of p53 increases glycolytic flux to promote anabolism and redox balance, two key processes that promote tumorigenesis (38).”
BackgroundInhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
Kon, N., Wang, D., Li, T., Jiang, L., Qiang, L., & Gu, W. (2018) · Oncotarget · doi:10.18632/oncotarget.23837 · Cited by 17
“It has been suggested that p53 promote cell survival under transient metabolic stress, and p53 is known to lower glucose utilization and promotes mitochondrial respiration and fatty acid oxidation [3, 53].”
BackgroundBaisantry, A., Berkenkamp, B., Rong, S., Bhayadia, R., Sörensen-Zender, I., Schmitt, R., & Melk, A. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00333.2018 · Cited by 18
“Apart from cell death, p53 activity is able to regulate multiple facets of AKI such as oxidative stress, autophagy, cell cycle progression, and senescence (12).”
BackgroundRaman Evidence of p53-DBD Disorder Decrease upon Interaction with the Anticancer Protein Azurin
Signorelli, S., Cannistraro, S., & Bizzarri, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123078 · Cited by 17
“p53 is an important tumor suppressor protein working as a central hub in a complex interaction network in which it regulates numerous cellular processes, including cell cycle progression, apoptosis induction, and DNA repair [1,2].”
BackgroundThe Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer
Hall, C., & Muller, P. A. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246188 · Cited by 18
“It is thought that p53′s response allows for survival and adaptation to mild stresses, but will initiate cell death if the stress is too much [4].”
BackgroundWu, Q., Yuan, X., Li, B., Han, R., Zhang, H., & Xiu, R. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s245959 · Cited by 18
Aboshanab, M. H. A., El-Nabarawi, M. A., Teaima, M. H. M., El‐Nekeety, A. A., Abdel‐Aziem, S. H., Hassan, N. S., & Abdel-Wahhab, M. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119639 · Cited by 17
Kim, Y. Y., Um, J., Shin, D. J., Jeong, D. J., Hong, Y. B., & Yun, J. (2021) · The FASEB Journal · doi:10.1096/fj.202002007r · Cited by 18
Indispensable role of Mdm2/p53 interaction during the embryonic and postnatal inner ear development
Laos, M., Sulg, M., Herranen, A., Anttonen, T., & Pirvola, U. (2017) · Scientific Reports · doi:10.1038/srep42216 · Cited by 18
SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling
Barzegar, M., Ma, S., Zhang, C., Chen, X., Gu, Y., Shang, C., Jiang, X., Yang, J., Nathan, C. O., Yang, S., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.298 · Cited by 17
“Over 50% of tumours harbour somatic mutations of TP53 gene (Kruiswijk et al, 2015).”
BackgroundLuo, Y., Huang, W., Zhang, H., & Liu, G. (2018) · Oncology Letters · doi:10.3892/ol.2018.8104 · Cited by 23
“The tumor protein P53 ( TP53 ) gene encodes the tumor suppressor protein p53, and is activated by various stresses including genotoxic damage, hypoxia and heat shock (12,13).”
OTUD7B is a new deubiquitinase targeting p53
Ding, C., Cao, L., Wang, R., Wu, Q., Li, M., Zhang, J., Thorne, R. F., Li, J., Ma, J., Wu, M., et al. (2025) · Theranostics · doi:10.7150/thno.103012 · Cited by 17
p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy
Cao, M., Gan, Y., Huang, Y., Tong, J., Chen, X., Chen, Y., Chen, B., Huang, R., Xie, B., Deng, J., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2415869122 · Cited by 18
“Upon moderate genotoxic stresses, p53 induces cell cycle arrest and promotes the repair of damaged DNA ( 7 , 8 ).”
Niedziela, D. A., Naranjo‐Lucena, A., Molina-Hernández, V., Browne, J. A., Martínez‐Moreno, Á., Pérez, J., MacHugh, D. E., & Mulcahy, G. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.729217 · Cited by 19
Cao, L., Fang, H., Yan, D., Wu, X. M., Zhang, J., & Chang, M. X. (2022) · Communications Biology · doi:10.1038/s42003-022-03856-1 · Cited by 18
Sanford, J. D., Franklin, D. A., Grois, G. A., Jin, A., & Zhang, Y. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104908 · Cited by 19
“Upregulation of VLCFA oxidation is also consistent with the general model of p53-mediated regulation of the cellular metabolism, in which p53 promotes mitochondrial oxidative metabolism of glutamine and lipids while inhibiting glucose uptake and glycolysis (1, 5, 24, 25).”
BackgroundMethodCheckpoint Inhibitors in Acute Myeloid Leukemia
Damiani, D., & Tiribelli, M. (2023) · Biomedicines · doi:10.3390/biomedicines11061724 · Cited by 18
“The p53 tumor suppressor is a transcription factor that regulates multiple cell functions, including mitotic division, DNA repair, apoptosis and senescence [60].”
BackgroundHarnessing ferroptosis for enhanced sarcoma treatment: mechanisms, progress and prospects
Zeng, J., Zhang, X., Lin, Z., Zhang, Y., Yang, J., Dou, P., & Liu, T. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00498-3 · Cited by 16
“However, under basal or low ROS stress, P53 may in turn inhibit ferroptosis, indicating its bidirectional effect [88].”
BackgroundGlobal Changes in Lipid Profiles of Mouse Cortex, Hippocampus, and Hypothalamus Upon p53 Knockout
Lee, S. T., Lee, J. C., Kim, J. W., Cho, S. Y., Seong, J. K., & Moon, M. H. (2016) · Scientific Reports · doi:10.1038/srep36510 · Cited by 17
Computer Analysis of Glioma Transcriptome Profiling: Alternative Splicing Events
Babenko, V. N., Губанова, Н. В., Брагин, А. О., Чадаева, И. В., Vasiliev, G. V., Medvedeva, I. V., Gaytan, A. S., Кривошапкин, А. Л., & Orlov, Y. L. (2017) · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics · doi:10.1515/jib-2017-0022 · Cited by 16
“p53 was originally found as an essential tumor suppressor preventing cell cycle progression and inducing apoptosis [48].”
BackgroundWang, M., Yang, J., & Wang, C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7083575 · Cited by 16
“In the nucleus, transcriptional activation of p53 upregulates the expression of Puma and Bax involved in the mitochondrial apoptosis pathway [38].”
BackgroundQi, Q., Huang, W., Zhang, H., Zhang, B., Sun, X., Ma, J., Zhu, C., & Wang, C. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-73 · Cited by 16
“Previous studies have shown that the p53 signaling pathway has a key role in multiple cellular processes, including the cell cycle and cancer progression (35,36).”
BackgroundWang, L., Zhang, L., Gong, X., Fu, J., Gan, Y., Hou, M., Nie, Q., Xiang, J., Xiao, Y., Wang, Y., et al. (2021) · Aging Cell · doi:10.1111/acel.13458 · Cited by 22
“At present, 17 serine/threonine residues of p53 have been identified and the activity of p53 is regulated by different kinases and phosphatases (Bode & Dong, 2004; Kruiswijk et al., 2015).”
BackgroundMelatonin Signaling Pathways Implicated in Metabolic Processes in Human Granulosa Cells (KGN)
Arjoune, A., & Sirard, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062988 · Cited by 16
“ability to induce cell cycle arrest, apoptosis, and senescence, TP53 was also reported to play an important role in metabolic regulation [90] through the maintenance of mitochondrial oxidative phosphorylation to promote fatty acid β-oxidation [91].”
BackgroundProtein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
Marques, M. A., de Andrade, G. C., Silva, J. L., & de Oliveira, G. A. P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.944955 · Cited by 16
“A list of other p53 target genes adopting controversial roles is presented in other reviews (Kruiswijk et al., 2015).”
BackgroundDinhof, C., Pirker, C., Kroiss, P., Kirchhofer, D., Gabler, L., Gojo, J., Lötsch-Gojo, D., Stojanovic, M., Timelthaler, G., Ferk, F., et al. (2020) · Cancers · doi:10.3390/cancers12113205 · Cited by 17
“Together, these data suggest that YK-4-279 might reverse the well-described cell death resistance mediated by the loss of wild-type p53 [41], partly based on interactions with oncogenic ETS1 signals especially in an MAPK-driven background.”
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.